Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 2/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.30 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19786644 | 0.85 | CYP1A1 (0.41) | CYP1A1CYP1B1CYP1A2 | |
| SCHEMBL21185796 | 0.80 | CYP1A1 (0.32) | CYP1A1CYP1B1 | |
| SCHEMBL17990620 | 0.79 | L3MBTL1 (0.35) | CYP1A1CYP1A2 | |
| SCHEMBL19784601 | 0.79 | CYP1A1 (0.32) | CYP1A1CYP1B1 | |
| SCHEMBL19786550 | 0.79 | PMM2 (0.36) | CYP1A1CYP1B1CYP1A2 | |
| SCHEMBL16484411 | 0.78 | PLA2G2A (0.34) | — | |
| SCHEMBL19786641 | 0.78 | CYP1A1 (0.40) | CYP1A1CYP1B1CYP1A2 | |
| SCHEMBL19786535 | 0.78 | ATM (0.41) | CYP1A1CYP1B1CYP1A2 | |
| SCHEMBL26809332 | 0.77 | PLA2G10 (0.31) | SIRT2SIRT1 | |
| SCHEMBL19786545 | 0.77 | CYP1A1 (0.37) | CYP1A1CYP1B1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11367839-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2022-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11367839-B2 | Compound for organic electric element, organic electric element using the same, and an electronic device thereof | ORAI2, KCNJ2, OR10J3 | CYP1A1 1602/4885CYP1B1 3315/4885CYP1A2 879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.